Market Overview

UPDATE: Credit Suisse Raises PT to $41 on HCA Holdings on Positive Reform Exposure

Share:
Related HCA
Watch These 7 Huge Put Purchases In Friday Trade
Analysts Give Healthcare Sector A Clean Bill Of Health
Dr. Michael Burry of 'The Big Short' Portfolio Review Shows Several Large Gains (GuruFocus)

Credit Suisse maintained HCA Holdings (NYSE: HCA) with a Market Perform rating and raised the price target from $30.00 to $39.00.

Credit Suisse noted, "HCA reported 4Q12 EPS of $0.91, well ahead of consensus of $0.82 and ahead of our $0.89 estimate, driven by strong organic volume growth. The company also issued 2013 guidance that fell below consensus, which was not overly surprising. However, shares traded off early highs as mgmt provided somewhat reserved commentary around healthcare reform, pointing to many uncertainties that still exist, and the likelihood of a multi-yr ramp. We continue to believe reform will be a meaningful positive in 2014 and the 4Q results reinforce the strong market position and execution by HCA."

HCA Holdings closed at $37.51 on Tuesday.

Latest Ratings for HCA

DateFirmActionFromTo
Jun 2016BernsteinInitiates Coverage onMarket Perform
Apr 2016Avondale PartnersMaintainsMarket Outperform
Mar 2016Credit SuisseMaintainsOutperform

View More Analyst Ratings for HCA
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Price Target Analyst Ratings

 

Related Articles (HCA)

View Comments and Join the Discussion!